Your browser doesn't support javascript.
loading
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Lachnit, Martin; Revendova, Kamila Zondra; Hradilek, Pavel; Bunganic, Radovan; Koristek, Zdenek; Jelinek, Tomas; Skutova, Monika; Piza, Radim; Volny, Ondrej; Hajek, Roman; Bar, Michal.
Affiliation
  • Lachnit M; Department of Hematooncology, University Hospital Ostrava, Czech Republic.
  • Revendova KZ; Department of Neurology, University Hospital Ostrava, Czech Republic.
  • Hradilek P; Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
  • Bunganic R; Department of Neurology, University Hospital Ostrava, Czech Republic.
  • Koristek Z; Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
  • Jelinek T; Department of Neurology, University Hospital Ostrava, Czech Republic.
  • Skutova M; Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Czech Republic.
  • Piza R; Department of Hematooncology, University Hospital Ostrava, Czech Republic.
  • Volny O; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Czech Republic.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava, Czech Republic.
  • Bar M; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Czech Republic.
Article de En | MEDLINE | ID: mdl-37337857

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Sclérose en plaques Limites: Humans Langue: En Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Sujet du journal: MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: République tchèque Pays de publication: République tchèque

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transplantation de cellules souches hématopoïétiques / Sclérose en plaques Limites: Humans Langue: En Journal: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Sujet du journal: MEDICINA Année: 2024 Type de document: Article Pays d'affiliation: République tchèque Pays de publication: République tchèque